Duterte kumpiyansa sa magiging resulta ng clinical trials para sa COVID-19 vaccines
President Duterte
SINABI ng Palasyo na kumpiyansa si Pangulong Duterte na magiging maganda ang resulta ng mga clinical trials para sa vaccine kontra coronavirus disease (COVID-19).
“We expect involvement in the vaccine clinical trials by the last quarter of 2020 with the Department of Science and Technology (DOST) taking a lead role,” sabi ni Presidential Spokesperson Harry Roque.
Idinagdag ni Roque na inatasan ang DOST na makipagtulungan sa Department of Health, World Health Organization at Food and Drug Administration Philippines para sa panuntunan, mga lugar at mga dalubhasang Pinoy na lalahok sa mga isasagawang vaccine clinical trials.
“The President wants to save the life of each and every Filipino and thus places great interest to these clinical trials,” ayon pa kay Roque.
Kasabay nito, sinabi ni Roque na pinag-aaralan na rin ng pamahalaan ang rekomendasyon ng DOST para sacpagtatayo ng mga research centers para simulan ang paggawa ng lokal na vaccine.
“The President will review the recommendations of DOST to establish the Pharmaceutical Development Center and the Virology Science and Technology Institute of the Philippines, which have already been approved by the Inter-Agency Task Force (IATF) last Friday, May 22,” dagdag ni Roque.
Sakaling aprubahan ni Duterte, kapwa magsisimula ang pagtatayo ng Pharmaceutical Group at Virology Research Group ngayong 2020.
“We understand that the DOST has included the establishment of the aforesaid research centers in its 2021 Budget Proposal,” sabi pa ni Roque.
Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Bandera. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.